ReviewBlood and lymphatic cancer : targets and therapy2025
The Ongoing Challenges of Managing Cytopenic Myelofibrosis in 2025: The Emergence of Non-JAK Inhibitor Therapies.
Samuel B Reynolds et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.